Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010.
about
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationTreatment schedules for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degenerationStem Cell Therapy for Treatment of Ocular DisordersEpidemiology of diabetic retinopathy, diabetic macular edema and related vision lossBlindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye ClinicsIntegrin αVβ5-mediated Removal of Apoptotic Cell Debris by the Eye Lens and Its Inhibition by UV Light Exposure.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Ultra-widefield fundus autofluorescence in age-related macular degeneration.Evaluation of Two Systems for Fundus-Controlled Scotopic and Mesopic Perimetry in Eye with Age-Related Macular Degeneration.Connexin46fs380 causes progressive cataracts.Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011.Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium.Thyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study.Ubiquitin carboxyl-terminal esterase L1 promotes proliferation of human choroidal and retinal endothelial cells.Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment.Frequency and Distribution of Refractive Error in Adult Life: Methodology and Findings of the UK Biobank StudyThe Montrachet Study: study design, methodology and analysis of visual acuity and refractive errors in an elderly populationCataract Surgery Visual Outcomes and Associated Risk Factors in Secondary Level Eye Care Centers of L V Prasad Eye Institute, India.Morphometric Optic Nerve Head Analysis in Glaucoma Patients: A Comparison between the Simultaneous Nonmydriatic Stereoscopic Fundus Camera (Kowa Nonmyd WX3D) and the Heidelberg Scanning Laser Ophthalmoscope (HRT III).Olive Oil Consumption and Age-Related Macular Degeneration: The Alienor Study.Cost of diabetic retinopathy and macular oedema in a population, an eight year follow upEvaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic EyesOptical Coherence Tomography in the UK Biobank Study - Rapid Automated Analysis of Retinal Thickness for Large Population-Based StudiesNumber of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-AnalysisAlbuminuria Is Associated with Open-Angle Glaucoma in Nondiabetic Korean Subjects: A Cross-Sectional Study.Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group.Population-based assessment of visual impairment among ethnic Dai adults in a rural community in ChinaVisualizing the Choriocapillaris Under Drusen: Comparing 1050-nm Swept-Source Versus 840-nm Spectral-Domain Optical Coherence Tomography Angiography.Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish populationVisual Impairment among Older Adults in a Rural Community in Eastern ChinaImaging individual neurons in the retinal ganglion cell layer of the living eyeHealthcare experiences of patients with age-related macular degeneration: have things improved? Cross-sectional survey responses of Macular Society members in 2013 compared with 1999.Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure.The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.Photo-damage, photo-protection and age-related macular degeneration.Evaluation of Cataract Surgery Outcomes at the Ban Phaeo Mobile Eye Clinic, Thailand.Visual impairment and blindness in Hungary.Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future.
P2860
Q24194251-06BF4255-5B2E-43D2-B294-A24514B4554BQ26472033-D19C8F99-1C9A-4090-858E-9E3352B3FECAQ26746974-0534790F-DE7F-4532-91D6-942EC6DF5CE7Q26775552-7C0ECC9F-4BFF-4CD0-9545-8DB36B8985A6Q30000044-E6CC4CEF-D718-4B37-93C4-270AE1CD2C80Q30354775-5FAAA3A9-6AEC-4DF1-9395-2789F00A0F17Q30411312-9E148D3E-DDA5-4AF8-B25B-6A6FED5BD45CQ30491978-770E9641-411C-4671-ACD9-0D397838BD9DQ33751571-B8C04BCE-5629-436F-9EC3-A4751F1A437FQ33902391-4F952376-A6A3-4BBF-943B-AE6E5B77D2A7Q34391848-C06185D6-F90C-4CF3-AA51-FA243F1823A3Q34408245-3BEAEE98-49DE-47D1-9E85-88237E92F624Q35266103-EC54D0C9-7B55-451F-A760-95514DFC5D24Q35530361-C9F701FD-1F97-4E50-A8A8-43EBBC583D4CQ35558017-F6FC4068-EC34-4A6E-A962-7CF30AD1DEE9Q35684611-9ABB2FBC-EDAF-4ED9-9056-623828C467B1Q35796617-45ED6AF5-5E89-4E98-85CA-F35F63E7ABE4Q35807144-A93397DA-68B9-49A8-AA2D-64D556B1727CQ35887969-82338FC6-59C3-4F58-A69C-DF8C45002147Q36055198-BDBBC8CD-A70D-476E-B9A9-EC3A86429DBDQ36088547-B9B4DE2E-30E9-4AC1-8777-5EAA5A78D0B4Q36095304-C46072EB-E848-4A2B-AB24-8E652E3C6F38Q36137281-EC7D149E-0002-43C7-AEA1-7BAFCDB62B00Q36157730-8A10B6C2-883D-4AEE-A73D-8624B2C90ACFQ36168951-B44F3A3B-5917-4D15-9651-2AF02BBA9077Q36231701-546B49FF-E925-4747-ABAF-A0AC3A65A42DQ36407317-CDABA270-B94C-4FEF-88B1-C5F7C350C16CQ36638542-87701908-E400-4125-9B42-213AA11CBE6AQ37197844-AD5B1CFB-1A56-4968-B956-CA3788E20436Q37310218-3D0D44B3-3ECC-47BE-B865-E362A32CECE3Q37335229-A858BE43-1A81-460D-A991-3CA0EF98E991Q37598983-F1350B40-DF01-48EB-BCB4-524471A9F86CQ37654216-003FBF81-C810-4ACB-BE8E-464AF4B1BFB5Q38387608-06A2B10F-0A8E-458C-8D23-FB094EADDD80Q38394355-3966DB22-9D65-41BD-9327-9C671F6C3E0BQ38551646-F3FB66C1-0789-4D81-9CEA-10909F5C5F80Q38555992-B0853667-1634-465F-990E-F979BC6EF1AAQ38611734-4BB70271-1830-435A-A350-09503645FC40Q38656865-34A1C767-8AF2-4BD1-A5A4-64ABA02DA595Q38692341-4683FEDE-92DF-417E-BC86-D6132439EB3C
P2860
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prevalence and causes of visio ...... and Central Europe: 1990-2010.
@en
type
label
Prevalence and causes of visio ...... and Central Europe: 1990-2010.
@en
prefLabel
Prevalence and causes of visio ...... and Central Europe: 1990-2010.
@en
P2093
P2860
P50
P1476
Prevalence and causes of visio ...... and Central Europe: 1990-2010.
@en
P2093
Holly Price
Jill Keeffe
Kovin Naidoo
Maurizio B Parodi
Richard A White
Rupert R A Bourne
Seth R Flaxman
Tien Y Wong
Vision Loss Expert Group of the Global Burden of Disease Study
P2860
P304
P356
10.1136/BJOPHTHALMOL-2013-304033
P407
P577
2014-03-24T00:00:00Z